Science Explorer Back to mapMap
Discussion
Researcher · Seagen (United States) · United States

Che‐Leung Law

Che‐Leung Law publishes mostly in Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and T-cell and B-cell Immunology.

ORCID 0009-0009-0025-1655 OpenAlex
World rank
#133,524
of 7,710,434 ranked researchers
Rank in United States
#50,636
of 1,627,098
Works
274
Citations
7.1k
Citations per work
25.8
h-index
42
i10-index 67Top 4.2% in Radiology, Nuclear Medicine and Imaging
Che‐Leung Law

What does Che‐Leung Law research?

Che‐Leung Law's work is mostly in Medicine (51%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 139 works · 50.8% of their workMedicine: 139 works · 50.8% of their workRadiology, Nuclear Medicine and Imaging: 61 works · 22.2% of their workOncology: 52 works · 19.0% of their workPathology and Forensic Medicine: 14 works · 5.1% of their workImmunology and Allergy: 12 works · 4.5% of their workLife Sciences: 86 works · 31.3% of their workImmunology and Microbiology: 55 works · 20.1% of their workImmunology: 55 works · 20.1% of their workBiochemistry, Genetics and Molecular Biology: 31 works · 11.2% of their workMolecular Biology: 31 works · 11.2% of their workEverything else: 49 works · 17.9% of their workTHEIR WORKChe‐Leung Law274works
Life Sciences31%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13950.8%
    1. Immunology and Microbiology5520.1%
    2. Biochemistry, Genetics and Molecular Biology3111.2%
  3. Everything else4917.9%
  1. 1Radiology, Nuclear Medicine and Imaging22% of their works
  2. 2Immunology20% of their works
  3. 3Oncology19% of their works
  4. 4Molecular Biology11% of their works
  5. 5Pathology and Forensic Medicine5% of their works
  6. 6Immunology and Allergy4% of their works

Research topics

Which keywords describe Che‐Leung Law's research?

The keywords of their largest research topics: Glycosylation, Fc Receptors, Therapeutic Antibodies, Lymphoma, Cancer Immunotherapy, Cancer, Breast Cancer and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Glycosylation912 topics
  2. Fc Receptors721 topic
  3. Therapeutic Antibodies721 topic
  4. Lymphoma412 topics
  5. Cancer Immunotherapy402 topics
  6. Cancer362 topics
  7. Breast Cancer311 topic
  8. HER2311 topic
  9. CAR T Cells221 topic
  10. Chimeric Antigen Receptor221 topic
  11. Foxp3221 topic
  12. TGF-ß221 topic
  13. Classification191 topic
  14. Glycans191 topic
  15. Immune System191 topic
  16. Molecular Profiling191 topic
  17. Dendritic Cells181 topic
  18. Immunity181 topic
  19. Cell Adhesion171 topic
  20. Integrins171 topic

Where does Che‐Leung Law work?

Che‐Leung Law's main affiliation in the publication record is Seagen (United States), United States.

How many publications and citations does Che‐Leung Law have?

OpenAlex counts 274 works and 7,082 citations for Che‐Leung Law, an h-index of 42, ranking #133,524 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Che‐Leung Law. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.